Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0.557. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01-MH046729
National Institutes of Health
Grant: P51OD011106
National Institute on Drug Abuse
Grant: ZIA000069
NIMH NIH HHS
Grant: R01 MH046729
Intramural NIH HHS
Grant: ZIA DA000069
NCRR NIH HHS
Grant: C06 RR020141
NICHD NIH HHS
Grant: P30 HD003352
NIGMS NIH HHS
Grant: T32 GM008688
NCRR NIH HHS
Grant: C06 RR015459
NIH HHS
Grant: P51 OD011107
National Institutes of Health
Grant: 3P51OD011106-60S1
Wisconsin National Primate Research Center Support
National Institutes of Health
Grant: 5P30HD003352-36
CORE--ANIMAL CARE AND BREEDING
National Institutes of Health
Grant: 5R01MH046729-17
Development and Regulation of Emotion in Primates
University of Wisconsin-Madison
Waisman Center
Office of the Director
FWCI
3.45
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals